Metabolic health Clinical Trials in Topeka, KS
As of October 2026, 11 paid clinical trials are recruiting for Metabolic health in Topeka, Kansas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Topeka
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
14 clinical trials for Metabolic health
·Clear filters·A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Top Research Study Locations in Topeka
Researchers run research studies in Topeka, KS at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Health System Saint Francis Campus | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 42 |
| Cotton O'Neil Cancer Center / Stormont Vail Health | Acute Myeloid Leukemia, Melanoma, Acute Lymphoblastic Leukemia | 10 |
| Cotton O'Neil Diabetes & Endocrinology | Diabetes Mellitus, Type 2, Obesity, Overweight | 6 |
| Cotton O'Neil Clinical Research Center | Overweight, Obesity, Atherosclerotic Cardiovascular Disease (ASCVD) | 5 |
| GSK Investigational Site | Liver Diseases, Alcoholic, Non-alcoholic Fatty Liver Disease, Chickenpox | 5 |
| Cotton O'Neil Digestive Health Center | Colitis, Ulcerative, Crohn Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 5 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Cotton O'Neil Diab & Endo Ctr | Cardiovascular Risk, Obesity, Type 2 Diabetes | 2 |
| Kansas Medical Clinic PA | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Cotton O'Neil Cancer Center | Diffuse Large B-Cell Lymphoma | 1 |
| Cotton O'Neil Cancer Center [Stormont Vail] | Esophageal Cancer, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Melanoma (Skin Cancer) | 1 |
| Cotton O'Neil Diabetes & Endocrinology Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Cotton O'Neil Mulvane | Type 2 Diabetes | 1 |
| Cotton O'Neil Research Center | Pneumococcal Infection | 1 |
| Cotton ONeil Clinical Research Center | Crohn's Disease | 1 |
| Cotton-O'Neil Clinical Research Center | Crohn Disease | 1 |
| Cotton-ONeil Diabetes and Endocrinology Center | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| KUCC MCA- TUKHS, Saint Francis Hospital | Non Small Cell Lung Cancer Stage | 1 |
| Topeka VA Hospital | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma | 1 |
| University of Kansas Health System St. Francis Campus | Lumbar Spinal Stenosis | 1 |
| VA Eastern Kansas Healthcare System | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 1 |
Active & Upcoming Studies in Topeka (2026)
Recruiting trials in Topeka grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin · Phase 3 · NRG Oncology
Diabetes & metabolic (21 active studies)
- A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity · Phase 3 · Novo Nordisk A/S
- ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (2 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Neurology & pain (1 active study)
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO · Phase 1 · National Cancer Institute (NCI)
Common conditions studied in Topeka
- Obesity (8 active studies)
- Overweight (7 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Crohn Disease (4 active studies)
- Diabetes Mellitus, Type 2 (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
Leading research sponsors in Topeka
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Eli Lilly and Company
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Topeka?
There are approximately 94 recruiting clinical trials in Topeka, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Topeka pay participants?
Most recruiting trials in Topeka compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Topeka?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Topeka?
The most common conditions under active study in Topeka include Obesity (8), Overweight (7), Anatomic Stage II Breast Cancer AJCC v8 (5), Crohn Disease (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Topeka?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Topeka on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Topeka?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Topeka?
Recruiting research sites in Topeka include University of Kansas Health System Saint Francis Campus, Cotton O'Neil Cancer Center / Stormont Vail Health, Cotton O'Neil Diabetes & Endocrinology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Topeka right now?
The largest active categories in Topeka are Cancer & tumors (49), Diabetes & metabolic (21), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.